TroVax - PDFSEARCH.IO - Document Search Engine

TroVax
Results: 20

#	Item
1	2011 Annual Report 20 years of GI Cancer Research Add to Reading List Source URL: gicancer.org.au Language: English - Date: 2013-01-14 19:04:01 Health Cancer research Prostate cancer Medical research Colorectal cancer Breast cancer War on Cancer TroVax Medicine Oncology Cancer organizations
2	FO R U M DISCRIMINATING FACTORS IN TREATMENT DECISIONS FOR CHEMOTHERAPY IN ELDERLY PATIENTS WITH COLORECTAL CANCER Add to Reading List Source URL: www.cancerforum.org.au Language: English - Date: 2009-05-12 10:00:00 Adjuvant therapy Chemotherapy Management of cancer Colorectal cancer Lung cancer Eastern Cooperative Oncology Group TroVax Breast cancer treatment Medicine Oncology Cancer treatments
3	Reproduced from Expert Review of Anticancer Therapy, December 2009, Vol. 9, No. 12, Pages[removed]with permission of Expert Reviews Ltd Editorial For reprint orders, please contact [removed] Add to Reading List Source URL: usir.salford.ac.uk Language: English - Date: 2011-10-13 04:41:52 TPBG Naptumomab estafenatox Renal cell carcinoma Tumor antigen Immunotherapy Immune system Sunitinib CD25 Cancer immunotherapy Medicine Immunology TroVax
4	Understanding Clinical Trials HR = 0.60 (CI : 0.51–0.70) p<0.0001 Add to Reading List Source URL: www.roche.com Language: English - Date: 2015-01-10 07:27:14 Research Clinical research Clinical trials Epidemiology End point of clinical trials Clinical endpoint Response Evaluation Criteria in Solid Tumors TroVax Bevacizumab Medicine Medical statistics Health
5	Understanding Clinical Trials HR = 0.60 (CI : 0.51–0.70) p<0.0001 Add to Reading List Source URL: www.roche.com Language: English - Date: 2014-05-27 02:22:43 Research Clinical research Clinical trials Epidemiology End point of clinical trials Clinical endpoint Response Evaluation Criteria in Solid Tumors TroVax Bevacizumab Medicine Medical statistics Health
6	Active Biotech and Ipsen announce completion of recruitment of tasquinimod clinical phase III study in prostate cancer Add to Reading List Source URL: hugin.info Language: English - Date: 2012-12-09 11:48:23 Clinical trial Ipsen Biomarker TroVax Oncolytics Biotech Medicine Health Prostate cancer
7	OXFORD BIOMEDICA PLC PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DECEMBER 2013 Oxford, UK – 10 April 2014: Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), the leading gene-based biopharmaceutical c Add to Reading List Source URL: www.oxfordbiomedica.co.uk Language: English - Date: 2014-04-10 02:09:25 Biotechnology Pharmacology TroVax Clinical research Oxford BioMedica Gene therapy Clinical trial Pharmaceutical industry Cell therapy Biology Medicine Science
8	GTSAB REPORT Recombinant DNA Advisory Committee Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2013-12-30 15:21:58 Bioethics Gene therapy HIV vaccine Granulocyte macrophage colony-stimulating factor Viral vector Insertional mutagenesis Thymidine kinase TroVax Biology Gene delivery HIV/AIDS
9	Serious and Other Selected Adverse Events Reported for Human Gene Transfer Protocols Recombinant DNA Advisory Commitee Meeting December 2007 Protocol Number: Protocol Title: Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2013-12-10 09:36:57 TroVax Neuroblastoma Glioblastoma multiforme Immunotherapy Gene therapy Metastasis Brain metastasis Radiation therapy Interferon Medicine Brain tumor Prostate cancer
10	Serious and Other Selected Adverse Events Reported for Human Gene Transfer Protocols Recombinant DNA Advisory Commitee Meeting June 2007 Protocol Number: Protocol Title: Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2013-12-10 09:43:28 Melanoma Radiation therapy Docetaxel TroVax Pancreatic cancer Gene therapy Medicine Biology Prostate cancer

UPDATE